IRON
IRON
NASDAQ · Biotechnology

Disc Medicine Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$78.91
+0.44 (+0.56%)
As of Nov 7, 1:35 AM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -71.5% upside
Low Target $15.33
Average Target $22.47
High Target $35.88
Current Price $78.91
Current
$78.91
Target
$22.47
$15.33 $22.47 avg $35.88
Scenario Analysis
Bear Case
$15.33
-80.6%
Low target
Base Case
$22.47
-71.5%
Avg target
Bull Case
$35.88
+-54.5%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$99.50
-20.7% from high
52-Week Low
$40.00
+97.3% from low
50-Day SMA
$71.21
+10.8% vs SMA
200-Day SMA
$70.84
+11.4% vs SMA
RSI (14)
50.0
Neutral
Target vs 52W High
$22.47
-77.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -40.7%